Study Stopped
Withdrawn from IRB at PI's request
Laser Therapy Treatment of Peri-implantitis.
Influence of Laser Therapy Upon Surgical Treatment of Peri-implantitis Lesions.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The primary objective of this study is to compare the clinical outcomes of using Er: YAG laser along with bone graft and barrier membrane to conventional mechanical debridement also with bone graft and barrier membrane in the treatment of peri-implantitis infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2013
CompletedFirst Posted
Study publicly available on registry
October 30, 2013
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedApril 3, 2015
April 1, 2015
1.2 years
October 7, 2013
April 1, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Perio Probing Depth
Change in probing depth from beginning of study to 6 months after intervention
Secondary Outcomes (1)
Bleeding on Probing
Change in bleeding on probing from beginning of study to 6 months after intervention
Study Arms (2)
Laser
EXPERIMENTALA laser will be used to clean out the area around the diseased implant to try to regain bone.
Mechanical
ACTIVE COMPARATORMechanical debridement will be used to clean out the area around the diseased implant to try to regain bone.
Interventions
This is a surgery that the patient will undergo and the laser will be used to clean the surface of the implant.
This is a surgery that the patient will undergo to have the surface of the implant cleaned using hand instruments.
Eligibility Criteria
You may qualify if:
- Patients, aged 18 - 85 years
- Physical status according to the American Society of Anesthesiologists (ASA) I or II, which includes patients who are systemically healthy or suffer under mild to moderate, but well controlled systemic diseases.
- Patients having a minimum of 1 dental implant with peri-implantitis.
- The dental implant with peri-implantitis has ≥ 3 threads exposed or pocket probing depth (PPD) ≥ 5mm, with bleeding on probing (BOP) and/or suppuration (pus).
- The implants are in function for at least 6 months
- No uncontrolled systemic disease or condition known to alter bone metabolism, like Osteoporosis, Osteopenia, Hyperparathyroidism, Paget's disease.
- Only rough surface implant will be included in this study
You may not qualify if:
- Long-term use of antibiotics \> 2 weeks in the past two months
- No peri-implantitis treatment in the last 2 months
- Patients taking medications known to modify bone metabolism (such as bisphosphonates, corticosteroids, Hormone replacement therapy for menopausal women, Parathyroid hormone, Denosumab, strontium ranelate).
- Pregnant females or those planning to become pregnant.
- Patients with a history of medically diagnosed oral cancer, bisphosphonate usage, Sepsis or those having adverse outcomes to oral procedures in the past, will be excluded
- Mobility of dental implants
- History of alcoholism or drug abuse
- Current smokers or quit smoking less than 6 months
- Diseases of the immune system or any medical condition that may influence the outcome (uncontrolled diabetes (HbA1c \>7)
- Patients with allergies known to affect one or more of the treatment provided in this study
- Polish surface implants
- Implants with trabecular surface
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan School of Dentistry
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fernando Suarez, DDS
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 7, 2013
First Posted
October 30, 2013
Study Start
January 1, 2016
Primary Completion
April 1, 2017
Last Updated
April 3, 2015
Record last verified: 2015-04